These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 32760208)

  • 1. Interleukin 22 in Liver Injury, Inflammation and Cancer.
    Wu Y; Min J; Ge C; Shu J; Tian D; Yuan Y; Zhou D
    Int J Biol Sci; 2020; 16(13):2405-2413. PubMed ID: 32760208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease.
    Kong X; Feng D; Mathews S; Gao B
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1(0 1):56-60. PubMed ID: 23855297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3.
    Ki SH; Park O; Zheng M; Morales-Ibanez O; Kolls JK; Bataller R; Gao B
    Hepatology; 2010 Oct; 52(4):1291-300. PubMed ID: 20842630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation.
    Radaeva S; Sun R; Pan HN; Hong F; Gao B
    Hepatology; 2004 May; 39(5):1332-42. PubMed ID: 15122762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice.
    Kong X; Feng D; Wang H; Hong F; Bertola A; Wang FS; Gao B
    Hepatology; 2012 Sep; 56(3):1150-9. PubMed ID: 22473749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease.
    Gao B
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):89-93. PubMed ID: 22320924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoding cell death signals in liver inflammation.
    Brenner C; Galluzzi L; Kepp O; Kroemer G
    J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice.
    Meng F; Wang K; Aoyama T; Grivennikov SI; Paik Y; Scholten D; Cong M; Iwaisako K; Liu X; Zhang M; Österreicher CH; Stickel F; Ley K; Brenner DA; Kisseleva T
    Gastroenterology; 2012 Sep; 143(3):765-776.e3. PubMed ID: 22687286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes.
    Zhang XW; Mi S; Li Z; Zhou JC; Xie J; Hua F; Li K; Cui B; Lv XX; Yu JJ; Hu ZW
    Oncotarget; 2017 Feb; 8(6):9922-9934. PubMed ID: 28039485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-33 overexpression is associated with liver fibrosis in mice and humans.
    Marvie P; Lisbonne M; L'helgoualc'h A; Rauch M; Turlin B; Preisser L; Bourd-Boittin K; Théret N; Gascan H; Piquet-Pellorce C; Samson M
    J Cell Mol Med; 2010 Jun; 14(6B):1726-39. PubMed ID: 19508382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory and anti-apoptotic roles of endothelial cell STAT3 in alcoholic liver injury.
    Miller AM; Wang H; Park O; Horiguchi N; Lafdil F; Mukhopadhyay P; Moh A; Fu XY; Kunos G; Pacher P; Gao B
    Alcohol Clin Exp Res; 2010 Apr; 34(4):719-25. PubMed ID: 20102572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Opportunities of IL-22 in Non-Alcoholic Fatty Liver Disease: From Molecular Mechanisms to Clinical Applications.
    Zai W; Chen W; Liu H; Ju D
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Regeneration and Hepatoprotective Effects of Interleukin 22 Fusion Protein on a Predamaged Liver Undergoing Partial Hepatectomy.
    Zhou H; Xie G; Mao Y; Zhou K; Ren R; Zhao Q; Wang H; Yin S
    J Immunol Res; 2018; 2018():5241526. PubMed ID: 30515423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
    Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
    Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-20 exacerbates acute hepatitis and bacterial infection by downregulating IκBζ target genes in hepatocytes.
    He Y; Feng D; Hwang S; Mackowiak B; Wang X; Xiang X; Rodrigues RM; Fu Y; Ma J; Ren T; Ait-Ahmed Y; Xu M; Liangpunsakul S; Gao B
    J Hepatol; 2021 Jul; 75(1):163-176. PubMed ID: 33610678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rilpivirine attenuates liver fibrosis through selective STAT1-mediated apoptosis in hepatic stellate cells.
    Martí-Rodrigo A; Alegre F; Moragrega ÁB; García-García F; Martí-Rodrigo P; Fernández-Iglesias A; Gracia-Sancho J; Apostolova N; Esplugues JV; Blas-García A
    Gut; 2020 May; 69(5):920-932. PubMed ID: 31530714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines.
    Lu DH; Guo XY; Qin SY; Luo W; Huang XL; Chen M; Wang JX; Ma SJ; Yang XW; Jiang HX
    World J Gastroenterol; 2015 Feb; 21(5):1531-45. PubMed ID: 25663772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-24 protects against liver injury in mouse models.
    Wang HH; Huang JH; Sue MH; Ho WC; Hsu YH; Chang KC; Chang MS
    EBioMedicine; 2021 Feb; 64():103213. PubMed ID: 33508745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.
    Brand S; Dambacher J; Beigel F; Zitzmann K; Heeg MH; Weiss TS; Prüfer T; Olszak T; Steib CJ; Storr M; Göke B; Diepolder H; Bilzer M; Thasler WE; Auernhammer CJ
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1019-28. PubMed ID: 17204547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.